WEV

(5R)-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4E,6E,9R,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4-methyl-5-propan-2-yl-alpha-D-threo-pentopyranose

Created:	2020-10-22
Last modified:	2021-03-17

Find Related PDB Entry
2 entries where WEV is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	102
Chiral Atom Count	12
Bond Count	103
Aromatic Bond Count	0

2D diagram of WEV

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(5R)-2,4-dideoxy-1-C-{(2S,3R,4S)-3-hydroxy-4-[(2R,3S,4E,6E,9R,10S,11R,12E,14Z)-10-hydroxy-3,15-dimethoxy-7,9,11,13-tetramethyl-16-oxo-1-oxacyclohexadeca-4,6,12,14-tetraen-2-yl]pentan-2-yl}-4-methyl-5-propan-2-yl-alpha-D-threo-pentopyranose
Synonyms	bafilomycin A1
Systematic Name (OpenEye OEToolkits)	(3~{Z},5~{E},7~{R},8~{S},9~{R},11~{E},13~{E},15~{S},16~{R})-3,15-dimethoxy-5,7,9,11-tetramethyl-16-[(2~{S},3~{R},4~{S})-4-[(2~{R},4~{R},5~{S},6~{R})-5-methyl-2,4-bis(oxidanyl)-6-propan-2-yl-oxan-2-yl]-3-oxidanyl-pentan-2-yl]-8-oxidanyl-1-oxacyclohexadeca-3,5,11,13-tetraen-2-one
Formula	C₃₅ H₅₈ O₉
Molecular Weight	622.83
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	COC1C=CC=C(CC(C)C(C(C=C(C=C(C(OC1C(C)C(O)C(C)C2(CC(O)C(C(O2)C(C)C)C)O)=O)OC)C)C)O)C
SMILES	CACTVS	3.385	CO[CH]1C=CC=C(C)C[CH](C)[CH](O)[CH](C)C=C(C)C=C(OC)C(=O)O[CH]1[CH](C)[CH](O)[CH](C)[C]2(O)C[CH](O)[CH](C)[CH](O2)C(C)C
SMILES	OpenEye OEToolkits	2.0.7	CC1CC(=CC=CC(C(OC(=O)C(=CC(=CC(C1O)C)C)OC)C(C)C(C(C)C2(CC(C(C(O2)C(C)C)C)O)O)O)OC)C
Canonical SMILES	CACTVS	3.385	CO[C@H]1/C=C/C=C(C)/C[C@@H](C)[C@H](O)[C@H](C)\C=C(C)\C=C(OC)\C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@H](O2)C(C)C
Canonical SMILES	OpenEye OEToolkits	2.0.7	C[C@@H]1C/C(=C/C=C/[C@@H]([C@H](OC(=O)/C(=C/C(=C/[C@H]([C@H]1O)C)/C)/OC)[C@@H](C)[C@H]([C@H](C)[C@]2(C[C@H]([C@@H]([C@H](O2)C(C)C)C)O)O)O)OC)/C
InChI	InChI	1.03	InChI=1S/C35H58O9/c1-19(2)32-24(7)27(36)18-35(40,44-32)26(9)31(38)25(8)33-28(41-10)14-12-13-20(3)15-22(5)30(37)23(6)16-21(4)17-29(42-11)34(39)43-33/h12-14,16-17,19,22-28,30-33,36-38,40H,15,18H2,1-11H3/b14-12+,20-13+,21-16+,29-17-/t22-,23-,24+,25+,26+,27-,28+,30+,31-,32-,33-,35-/m1/s1
InChIKey	InChI	1.03	XDHNQDDQEHDUTM-XJKSCTEHSA-N

Related Resource References

Resource Name	Reference
PubChem	5702538

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.